IBDEI0GM ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8070,2)
 ;;=^268710
 ;;^UTILITY(U,$J,358.3,8071,0)
 ;;=364.21^^58^605^46
 ;;^UTILITY(U,$J,358.3,8071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8071,1,3,0)
 ;;=3^Fuch's Hetero Cyclitis
 ;;^UTILITY(U,$J,358.3,8071,1,4,0)
 ;;=4^364.21
 ;;^UTILITY(U,$J,358.3,8071,2)
 ;;=^48468
 ;;^UTILITY(U,$J,358.3,8072,0)
 ;;=364.23^^58^605^81
 ;;^UTILITY(U,$J,358.3,8072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8072,1,3,0)
 ;;=3^Lens-Induced Iridocyclitis
 ;;^UTILITY(U,$J,358.3,8072,1,4,0)
 ;;=4^364.23
 ;;^UTILITY(U,$J,358.3,8072,2)
 ;;=^268713
 ;;^UTILITY(U,$J,358.3,8073,0)
 ;;=364.51^^58^605^8
 ;;^UTILITY(U,$J,358.3,8073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8073,1,3,0)
 ;;=3^Atrophy Iris Essential/Progressive
 ;;^UTILITY(U,$J,358.3,8073,1,4,0)
 ;;=4^364.51
 ;;^UTILITY(U,$J,358.3,8073,2)
 ;;=^268718
 ;;^UTILITY(U,$J,358.3,8074,0)
 ;;=364.53^^58^605^100
 ;;^UTILITY(U,$J,358.3,8074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8074,1,3,0)
 ;;=3^Pigment Dispersion w/o Glauc
 ;;^UTILITY(U,$J,358.3,8074,1,4,0)
 ;;=4^364.53
 ;;^UTILITY(U,$J,358.3,8074,2)
 ;;=^268720
 ;;^UTILITY(U,$J,358.3,8075,0)
 ;;=364.57^^58^605^33
 ;;^UTILITY(U,$J,358.3,8075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8075,1,3,0)
 ;;=3^Degen Ciliary Body Changes
 ;;^UTILITY(U,$J,358.3,8075,1,4,0)
 ;;=4^364.57
 ;;^UTILITY(U,$J,358.3,8075,2)
 ;;=^268728
 ;;^UTILITY(U,$J,358.3,8076,0)
 ;;=364.60^^58^605^26
 ;;^UTILITY(U,$J,358.3,8076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8076,1,3,0)
 ;;=3^Cyst,Idiopathic
 ;;^UTILITY(U,$J,358.3,8076,1,4,0)
 ;;=4^364.60
 ;;^UTILITY(U,$J,358.3,8076,2)
 ;;=^268733
 ;;^UTILITY(U,$J,358.3,8077,0)
 ;;=364.73^^58^605^97
 ;;^UTILITY(U,$J,358.3,8077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8077,1,3,0)
 ;;=3^Peripheral Ant Synechiae
 ;;^UTILITY(U,$J,358.3,8077,1,4,0)
 ;;=4^364.73
 ;;^UTILITY(U,$J,358.3,8077,2)
 ;;=^268740
 ;;^UTILITY(U,$J,358.3,8078,0)
 ;;=364.75^^58^605^107
 ;;^UTILITY(U,$J,358.3,8078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8078,1,3,0)
 ;;=3^Pupillary Abnormalities
 ;;^UTILITY(U,$J,358.3,8078,1,4,0)
 ;;=4^364.75
 ;;^UTILITY(U,$J,358.3,8078,2)
 ;;=^268742
 ;;^UTILITY(U,$J,358.3,8079,0)
 ;;=364.76^^58^605^58
 ;;^UTILITY(U,$J,358.3,8079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8079,1,3,0)
 ;;=3^Iridodialysis
 ;;^UTILITY(U,$J,358.3,8079,1,4,0)
 ;;=4^364.76
 ;;^UTILITY(U,$J,358.3,8079,2)
 ;;=^265499
 ;;^UTILITY(U,$J,358.3,8080,0)
 ;;=364.77^^58^605^3
 ;;^UTILITY(U,$J,358.3,8080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8080,1,3,0)
 ;;=3^Angle Recession w/o Glauc
 ;;^UTILITY(U,$J,358.3,8080,1,4,0)
 ;;=4^364.77
 ;;^UTILITY(U,$J,358.3,8080,2)
 ;;=^268743
 ;;^UTILITY(U,$J,358.3,8081,0)
 ;;=364.89^^58^605^62
 ;;^UTILITY(U,$J,358.3,8081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8081,1,3,0)
 ;;=3^Iris/Ciliary D/O,Other
 ;;^UTILITY(U,$J,358.3,8081,1,4,0)
 ;;=4^364.89
 ;;^UTILITY(U,$J,358.3,8081,2)
 ;;=^268745
 ;;^UTILITY(U,$J,358.3,8082,0)
 ;;=364.9^^58^605^61
 ;;^UTILITY(U,$J,358.3,8082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8082,1,3,0)
 ;;=3^Iris/Ciliary Body D/O,Unspec
 ;;^UTILITY(U,$J,358.3,8082,1,4,0)
 ;;=4^364.9
 ;;^UTILITY(U,$J,358.3,8082,2)
 ;;=^123847
 ;;^UTILITY(U,$J,358.3,8083,0)
 ;;=370.00^^58^605^25
 ;;^UTILITY(U,$J,358.3,8083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8083,1,3,0)
 ;;=3^Corneal Ulcer NOS
 ;;^UTILITY(U,$J,358.3,8083,1,4,0)
 ;;=4^370.00
 ;;^UTILITY(U,$J,358.3,8083,2)
 ;;=^28441
 ;;^UTILITY(U,$J,358.3,8084,0)
 ;;=370.20^^58^605^66
 ;;^UTILITY(U,$J,358.3,8084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8084,1,3,0)
 ;;=3^Keratitis,Superfic Unspec
